TELA Bio, Inc.
TELA
$1.30
-$0.02-1.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.34% | 12.78% | 18.56% | 29.34% | 31.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.34% | 12.78% | 18.56% | 29.34% | 31.64% |
| Cost of Revenue | 21.59% | 20.59% | 24.89% | 33.34% | 31.11% |
| Gross Profit | 14.00% | 9.36% | 15.75% | 27.61% | 31.87% |
| SG&A Expenses | -2.42% | -0.45% | 6.44% | 21.69% | 25.25% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.27% | 2.40% | 8.26% | 21.16% | 23.91% |
| Operating Income | 19.73% | 12.09% | 5.40% | -10.63% | -14.54% |
| Income Before Tax | 3.04% | -8.04% | 18.60% | 5.10% | 3.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.18% | -7.81% | 18.91% | 5.10% | 3.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.18% | -7.81% | 18.91% | 5.10% | 3.22% |
| EBIT | 19.73% | 12.09% | 5.40% | -10.63% | -14.54% |
| EBITDA | 20.55% | 12.80% | 5.97% | -10.72% | -14.79% |
| EPS Basic | 34.86% | 15.52% | 32.64% | 18.07% | 23.82% |
| Normalized Basic EPS | 44.70% | 28.59% | 17.54% | 3.09% | 10.12% |
| EPS Diluted | 34.86% | 15.52% | 32.75% | 18.19% | 23.93% |
| Normalized Diluted EPS | 44.70% | 28.59% | 17.54% | 3.09% | 10.12% |
| Average Basic Shares Outstanding | 58.23% | 39.17% | 24.75% | 14.37% | 25.37% |
| Average Diluted Shares Outstanding | 58.23% | 39.17% | 24.75% | 14.37% | 25.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |